Posts Tagged ‘C’

« Older Entries
Newer Entries »

EXFO excels, C steady, LEDS falls

Thursday, January 13th, 2011

Exfo Inc. (Nasdaq: EXFO) shares gained 21.7 percent to $9.21 Thursday. Volume was 1,068,654, leaps and bounds better than its full-day volume average of 34,688, after the Canadian telecom-testing-equipment maker reported first-quarter earnings that exceeded its own forecast.

Citigroup (NYSE: C) traded in 179,303,239 shares Thursday, about a third its daily average of 547,887,000. Prices for C were flat at $5.07.

SemiLEDS Corporation (Nasdaq: LEDS) fell 33 percent Thursday to $19.17 Volume for the stock was 4,007,597 shares, eight times its full-day average. The company said new pricing pressures will lead to slimmer profit and revenue for the newly-public company over the next three months.

Tags: , , , , , ,
Posted in Financial Stocks, Technology Stocks | No Comments »

ZLC a jewel, C moving, LF dives

Wednesday, January 12th, 2011

Zale Corp.(NYSE: ZLC) shares gained 31.8% Wednesday to $5.31, on volume of 4,860,848 shares, or nearly five times its full-day average. This, after the jewelry retailer said sales at stores open at least a year rose 8.5% during the holiday-shopping season

Citigroup Inc. (NYSE: C) traded in 164,176,079 shares early Wednesday, catching up on its all-day average of 545,199,000. Prices for C moved forward 1.9 percent to $5.04.

Leapfrog Enterprises Inc. (NYSE: LF) fell 24.7 percent Wednesday to $4.07. Volume for the stock was 4,035,933 shares or nearly seven times its daily average, after forecasting 2010 earnings below expectations.

Tags: , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks | 1 Comment »

GENE displays sheen, C trades widely, STRA strays

Monday, January 10th, 2011

Genetic Technologies Ltd (Nasdaq: GENE) grew 71 percent in price Monday to $2.53. Volume of 191,089 shares proved nearly 100 times its full-day average volume. GENE is a leading-edge genetic testing business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of DNA on health.

Citgroup Inc. (NYSE: C) traded Monday in 176,181,317 shares, compared to its daily average of 546,005,000. Prices for the stock tailed off 0.9 percent to $4.89. Citigroup Inc. today announced that it has received requisite consents from holders of CitiFinancial Credit Company’s 6.625% Notes due 2015 and is extending the early tender date and consent date of its exchange offer.

Strayer Education Inc. (Nasdaq: STRA) lost 22.2 percent in Monday trading to $119.30. Volume for the stock was 1,334,882 shares, more than four times its daily average. STRA is an education services holding company that owns Strayer University and certain other assets.

Tags: , , , , , , ,
Posted in Financial Stocks, Health Care Stocks | 1 Comment »

HAUP hops, C jumping, PSUN sets

Thursday, January 6th, 2011

Hauppage Digital Inc. (Nasdaq: HAUP) rushed ahead 34.2 percent in price Thurday to $3.18. Volume of 3,586,458 shares overwhelmed its daily average of 256,305. The world’s leading developer and manufacturer of TV tuner products for personal computers launched its new Colossus internal PCI Express board capable of recording component video and unencrypted HDMI video at up to 1080i from sources such as the Xbox360 and digital SLR cameras.

Citigroup Inc. (NYSE: C) was busy Thursday, trading in 343,135,504 shares, catching up on a full-day average of 541,733,000. Prices for the stock gained 0.3 percent to $4.99.

Pacific Sunwear of California, Inc. (Nasdaq: PSUN) faltered 15 percent to $4.65 on volume of 752,638 shares, catching up on its daily average of 986,812. Pacific announced that its quarter-to-date same-store sales through January 1, 2011 declined 7%. The Company’s fourth quarter and fiscal year ends on January 29, 2011.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks, Technology Stocks | No Comments »

OPXA soars, C deals, TSTY turns south

Wednesday, January 5th, 2011

Opexa Therapeutics Inc. (Nasdaq: OPXA) shares leaped 80.8 percent to $2.82. Volume of 3.2 million shares, triumphed over usual volume of 70,317. The Woodlands, Texas-based cell therapy company said that after meeting twice with the U.S. Food and Drug Administration, it is preparing a Phase III clinical study of Tovaxin, a drug intended to treat multiple sclerosis.

Citigroup (NYSE:C) was a volume leader Wednesday, trading in 122,929,357, gaining on a full-day average of 538,020,000. Shares gained 0.7 percent to $4.94.

Tasty Baking Company (Nasdaq: TSTY) shed 33 percent to $4.31, on 159,504, compared to usual volume of below 10,000. TSTY announced today that preliminary financial data indicate the Company did not achieve the expected operational cash savings from this bakery during the fourth quarter.

Tags: , , , , , , ,
Posted in Consumer Discretionary Stocks, Financial Stocks, Health Care Stocks | No Comments »

« Older Entries
Newer Entries »